Close Menu

NEW YORK – Luminex reported after the close of the market on Monday that its fourth quarter revenues rose 12 percent year over year, slightly above its preliminary estimates announced last month.

For the three months ended Dec. 31, 2019, the firm said revenues rose to $90.5 million compared to $81.1 million a year ago, and short of Wall Street analysts' consensus estimate of $90.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.